Risk factors for melioidosis and bacteremic melioidosis

Clinical Infectious Diseases

Volumn 29, Issue 2, 1999, Pages 408-413

  Suputtamongkol, Yupin ^a,b,c,d,e   Chaowagul, Wipada ^a,b,c,d,e   Chetchotisakd, Ploenchan ^a,b,c,d,e   Lertpatanasuwun, Nimit ^a,b,c,d,e   Intaranongpai, Sunanta ^a,b,c,d,e   Ruchutrakool, Theera ^a,b,c,d,e   Budhsarawong, Duangkao ^a,b,c,d,e   Mootsikapun, Piroon ^a,b,c,d,e   Wuthiekanun, Vanaporn ^a,b,c,d,e   Teerawatasook, Nitaya ^a,b,c,d,e   Lulitanond, Aroonlug ^a,b,c,d,e  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Sappasitthiprasong Hospital   (Thailand)

^c KHON KAEN UNIVERSITY   (Thailand)

^d Department of Medicine   (Thailand)

^e Surin Hospital   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTEREMIA; BURKHOLDERIA PSEUDOMALLEI; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HUMAN; KIDNEY DISEASE; MALE; MELIOIDOSIS; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THAILAND;

EID: 0032777489     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520223     Document Type: Article

References (13)

1. 1. Wuthiekanun V, Smith MD, Dance DAB, White NJ. Isolation of Pseudomonas pseudomallei from soil in northeastern Thailand. Trans R Soc Trop Med Hyg 1995;41:41-3.
2. 2. Chaowagul W, White NJ, Dance DAB, et al. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis 1989;159:890-9.
3. 3. White NJ, Dance DA, Chaowagul W, Wattanagoon Y, Wuthiekanun V, Pitakwatchara N. Halving of mortality of severe melioidosis by ceftazidime. Lancet 1989;2:697-701.
4. 4. Sookpranee M, Boonma P, Susaengrat W, Bhuripanyo K, Punyagupta S. Multicenter prospective randomized trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe melioidosis. Antimicrob Agents Chemother 1992;36:158-62.
5. 5. Suputtamongkol Y, Rajchanuwong A, Chaowagul W, et al. Ceftazidime vs. amoxicillin/clavulanate in the treatment of severe melioidosis. Clin Infect Dis 1994;19:846-53.
6. 6. Rajchanuvong A, Chaowagul W, Suputtamongkol Y, Smith MD, Dance DA, White NJ. A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis. Trans R Soc Trop Med Hyg 1995;89:546-9.
7. 7. Chaowagul W, Suputtamongkol Y, Dance DA, Rajchanuvong A, Pattara-Arechachai J, White NJ. Relapse in melioidosis: incidence and risk factors. J Infect Dis 1993;168:1181-5.
8. 8. Leclarasamee A, Bovomkitti S. Melioidosis: review and update. Rev Infect Dis 1989;11:413-25.
9. 9. Suputtamongkol Y, Hall AJ, Dance DAB, et al. The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand. Int J Epidemiol 1994;23:1082-90.
10. 10. Puthucheary SD, Parasakthi N, Lee MK. Septicaemic melioidosis: a review of 50 cases from Malaysia. Trans R Soc Trop Med Hyg 1992;86: 683-5.
11. 11. Schuckit M. Alcoholism and drug dependency. In: Fauci A, Braunwald E, Isselbecher K, et al., eds. Harrison's principles of internal medicine. 14th ed. Vol 2. New York: McGraw-Hill, 1998:2503-8.
12. 12. Merianos A, Patel M, Lane JM, et al. The 1990-1991 outbreak of melioidosis in the Northern Territory of Australia: epidemiology and environmental studies. Southeast Asian J Trop Med Public Health 1993;24:425-35.
13. 13. Bryan LE, Wong S, Woods DE, Dance DAB, Chaowagul W. Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide from Pseudomonas pseudomallei. Can J Infect Dis 1994;9:170-8.